Log in

3D-QSAR studies of 8-substituted chromen-4-one-2-carboxylic acid derivatives as potent agonists for the orphan G protein-coupled receptor 35

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

GPR35, an orphan G protein-coupled receptor, has attracted much attention as a novel therapeutic target for the treatment of diabetes, hypertension, etc. Recently, 8-substituted chromen-4-one-2-carboxylic acid derivatives were identified as potent and selective agonists for human GPR35. In the present study, the three-dimensional quantitative structure–activity relationship (3D-QSAR) models were developed for a series of 8-substituted chromen-4-one-2-carboxylic acid derivatives using comparative molecular field analysis (CoMFA), comparative molecular similarity indices analysis (CoMSIA), and Topomer CoMFA techniques implemented in the SYBYL software packages. The statistically significant models were obtained with 30 compounds in training set by ligand-based atom-by-atom matching alignment, which were further validated by a test set of eight compounds. The CoMFA model resulted in cross-validated coefficient (q 2) value of 0.610 using 4 components, non-cross-validated coefficient (r 2) value of 0.918 with estimated F value of 69.917, and standard error of estimate (SEE) of 0.352. While the CoMSIA model combined with steric, electrostatic and hydrophobic fields were finally selected (q 2 = 0.646, r 2 = 0.800, F = 53.852, SEE = 0.489, N = 2). For the Topomer CoMFA model, the better statistics were obtained based on fragment units (q 2 = 0.746, r 2 = 0.979, F = 146.294, SEE = 0.175, N = 7). Furthermore, the contour maps obtained from 3D-QSAR studies were appraised for activity trends for the compounds analyzed. The results indicate that steric, electrostatic, and hydrophobic substituents play a significant role in the agonist activity. The data generated from the present study will further help design novel, potent, and selective agonists for GPR35.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Abbreviations

3D-QSAR:

Three-dimensional quantitative structure–activity relationship methods

CoMFA:

Comparative molecular field analysis

CoMSIA:

Comparative molecular similarity indices analysis

GPCRs:

G protein-coupled receptors

GPR35:

G protein-coupled receptor 35

LOO:

Leave-one-out procedure

L5O:

Leave-five-out procedure

N :

Optimal number of components

PLS:

Partial least square method

PRESS:

Predictive sum of squares

q 2 :

The cross-validated correlation coefficient

q 2L5O :

Cross-validated correlation coefficient for leave-five-out

r 2 :

Non-cross-validated correlation coefficient

SEE:

Standard error of estimate

References

  • Chandrasekaran V, McGaughey GB, Cavallito CJ, Bowen JP (2004) Three-dimensional quantitative structure–activity relationship (3D-QSAR) analyses of choline acetyltransferase inhibitors. J Mol Graph Model 23:69–76

    Article  CAS  PubMed  Google Scholar 

  • Cho SJ, Tropsha A (1995) Cross-validated R2-guided region selection for comparative molecular field analysis: a simple method to achieve consistent results. J Med Chem 38:1060–1066

    Article  CAS  PubMed  Google Scholar 

  • Clark M, Cramer RD, Vanopdenbosch N (1989) Validation of the general-purpose tripos 5.2 force-field. J Comput Chem 10:982–1012

    Article  CAS  Google Scholar 

  • Cosi C, Mannaioni G, Cozzi A, Carla V, Sili M, Cavone L, Maratea D, Moroni F (2011) G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: studies on the antinociceptive effects of kynurenic acid and zaprinast. Neuropharmacology 60:1227–1231

    Article  CAS  PubMed  Google Scholar 

  • Cramer RD (2012) R-group template CoMFA combines benefits of “ad hoc” and topomer alignments using 3D-QSAR for lead optimization. J Comput Aided Mol Des 26:805–819

    Article  CAS  PubMed  Google Scholar 

  • Ding W, Sun M, Luo S, Xu T, Cao Y, Yan X, Wang Y (2013) A 3D QSAR study of betulinic acid derivatives as anti-tumor agents using topomer CoMFA: model building studies and experimental verification. Molecules 18:10228–10241

    Article  CAS  PubMed  Google Scholar 

  • Funke M, Thimm D, Schiedel AC, Müller CE (2013) 8-Benzamidochromen-4-one-2-carboxylic acids: potent and selective agonists for the orphan G protein-coupled receptor GPR35. J Med Chem 56:5182–5197

    Article  CAS  PubMed  Google Scholar 

  • Heikamp K, Bajorath J (2013) The future of virtual compound screening. Chem Biol Drug Des 81:33–40

    Article  CAS  PubMed  Google Scholar 

  • Jenkins L, Alvarez-Curto E, Campbell K, de Munnik S, Canals M, Schlyer S, Milligan G (2011) Agonist activation of the G protein-coupled receptor GPR35 involves transmembrane domain III and is transduced via Gα13 and β-arrestin-2. Br J Pharmacol 162:733–748

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Klebe G, Abraham U, Mietzner T (1994) Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J Med Chem 37:4130–4146

    Article  CAS  PubMed  Google Scholar 

  • Mackenzie AE, Lappin JE, Taylor DL, Nicklin SA, Milligan G (2011) GPR35 as a novel therapeutic target. Front Endocrinol (Lausanne) 2:1–10

    Google Scholar 

  • Milligan G (2002) Strategies to identify ligands for orphan G-protein-coupled receptors. Biochem Soc Trans 30:789–793

    Article  CAS  PubMed  Google Scholar 

  • Min KD, Asakura M, Nakamaru K, Liao Y, Okazaki H, Takahashi T, Fujimoto K, Ito S, Takahashi A, Asanuma H, Yamazaki S, Minamino T, Sanada S, Seguchi O, Nakano A, Ando Y, Otsuka T, Furukawa H, Isomura T, Takashima S, Mochizuki N, Kitakaze M (2010) Identification of genes related to heart failure using global gene expression profiling of human failing myocardium. Biochem Biophys Res Commun 393:55–60

    Article  CAS  PubMed  Google Scholar 

  • Neetoo-Isseljee Z, Mackenzie AE, Southern C, Jerman J, McIver EG, Harries N, Taylor DL, Milligan G (2013) High-throughput identification and characterization of novel, species-selective GPR35 agonists. J Pharmacol Exp Ther 344:568–578

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Ohshiro H, Tonai-Kachi H, Ichikawa K (2008) GPR35 is a functional receptor in rat dorsal root ganglion neurons. Biochem Biophys Res Commun 365:344–348

    Article  CAS  PubMed  Google Scholar 

  • Pal K, Melcher K, Xu HE (2012) Structure and mechanism for recognition of peptide hormones by Class B G-protein-coupled receptors. Acta Pharmacol Sin 33:300–311

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Taniguchi Y, Tonai-Kachi H, Shinjo K (2006) Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35. FEBS Lett 580:5003–5008

    Article  CAS  PubMed  Google Scholar 

  • Thimm D, Funke M, Meyer A, Müller CE (2013) 6-Bromo-8-(4-[(3)H]methoxybenzamido)-4-oxo-4H-chromene-2-carboxylic acid: a powerful tool for studying orphan G protein-coupled receptor GPR35. J Med Chem 56:7084–7099

    Article  CAS  PubMed  Google Scholar 

  • Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L (2006) Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J Biol Chem 281:22021–22028

    Article  CAS  PubMed  Google Scholar 

  • Wang H, Du Z, Zhang C, Tang Z, He Y, Zhang Q, Zhao J, Zheng X (2014) Biological evaluation and 3D-QSAR studies of curcumin analogues as aldehyde dehydrogenase 1 inhibitors. Int J Mol Sci 15:8795–8807

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  • Wilson GL, Lill MA (2011) Integrating structure-based and ligand-based approaches for computational drug design. Future Med Chem 3:735–750

    Article  CAS  PubMed  Google Scholar 

  • Yang Y, Lu JY, Wu X, Summer S, Whoriskey J, Saris C, Reagan JD (2010) G-protein-coupled receptor 35 is a target of the asthma drugs cromolyn disodium and nedocromil sodium. Pharmacology 86:1–5

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to acknowledge the financial supports from the National Natural Science Foundation of China (No. 81101687), the “Innovative Drug Development” State Key Science and Technology of China (No. 2009ZX09103-104), Program for the Top Science and Technology Innovation Teams of Higher Learning Institutions of Shanxi Province, and the Technology Innovation Team of Shanxi Province.

Conflict of interest

The author declares that there are no conflicts of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Qingshan Li.

Additional information

Taigang Liang and Chaoqun Yan have contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liang, T., Yan, C., Yang, L. et al. 3D-QSAR studies of 8-substituted chromen-4-one-2-carboxylic acid derivatives as potent agonists for the orphan G protein-coupled receptor 35. Med Chem Res 24, 2183–2194 (2015). https://doi.org/10.1007/s00044-014-1287-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-014-1287-3

Keywords

Navigation